Lumipulse® G Amyloid-beta42 Assay

Chemiluminescent assay kit for quantitative detection of beta amyloid 1-42 in patient samples. Designed for early diagnosis and monitoring of Alzheimer's disease and neurodegenerative disorders. Provides rapid, sensitive results using chemiluminescent immunoassay methodology for clinical laboratory use.

Chemiluminescent immunoassay kit for detecting neurofilament protein biomarkers associated with Alzheimer's disease. Enables early diagnosis and disease monitoring in clinical laboratory settings. Provides quantitative measurement with high sensitivity and specificity for neurodegenerative disease assessment.

Chemiluminescent assay kit for quantitative detection of phosphorylated tau-181 (p-tau181) protein in human serum or plasma. Used for early diagnosis and monitoring of neurodegenerative diseases, particularly Alzheimer's disease and other tauopathies. Provides high sensitivity and specificity for tau pathology assessment in clinical and research laboratories.

In vitro diagnostic assay kit for quantitative detection of Alzheimer-associated neurofilament protein using fluorometric chromatography. Enables early-stage diagnosis and monitoring of neurodegenerative disease progression in clinical laboratories. Provides rapid, sensitive biomarker measurement for cognitive impairment assessment.

Enzyme-linked immunoassay kit for quantitative detection of phosphorylated tau-181 (p-tau181) in human serum or plasma. Designed for early diagnosis and monitoring of neurodegenerative diseases, particularly Alzheimer's disease and dementia. Provides rapid, reliable biomarker measurement for clinical and research applications.

A diagnostic test kit for measuring serum amyloid A levels using fluorescence immunochromatography method. It is used for acute phase response and inflammation assessment in clinical laboratory diagnostics.

Latex enhanced immunoturbidimetric assay for detecting serum amyloid A levels. Used as an inflammation marker in clinical laboratory diagnostics.

Chemiluminescence immunoassay for anemia-related biomarkers and hematological parameters. Registered diagnostic test product supporting anemias diagnosis and evaluation. Included in the company's broad chemiluminescence portfolio.

Solid phase sandwich ELISA for the determination of human Aβ (1-x) in EDTA-plasma, cerebrospinal fluids, serum, cell culture media, or extracts from brain tissue. This assay measures various forms of amyloid beta peptides relevant to Alzheimer's disease research. For research use only, not for use in diagnostic procedures.

Pure native amyloid-beta for Alzheimer's disease diagnostic assay development. Serves as a reference material in neurodegenerative disorder testing.

Solid phase sandwich ELISA for the determination of human sAPPα in serum, EDTA plasma, cerebrospinal fluids, and cell culture supernatant. This highly sensitive assay measures soluble Amyloid Precursor Protein alpha in Alzheimer's disease research. For research use only, not for use in diagnostic procedures.

Quantitatively determines amyloid-beta 42 concentration in EDTA plasma using chemiluminescence analysis. Supports research in Alzheimer's disease and neurological assessment.